← Evidence map

ArticleDiagnostics (Basel, Switzerland)2013

Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma.

Abby L Cosentino-Boehm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2013
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26835666